Evaluation of Direct-acting Antiviral Drugs for Hepatitis C patients below 30 years age in Sialkot, Pakistan

Background: Infection of Hepatitis C virus (HCV) is major contributor in liver problems, affecting nearly more than 70 million people all over the world. Top ten countries which are affected by Hepatitis, also include Pakistan. Medical science has entered a new era HCV therapy elimination infection and disease real possibility. In asia, Genotype 3 chronic hepatitis genotype as compared to other genotypes. Direct-acting antiviral drugs famous for their high efficacy rate, but less work done Asia. Methods: A follow up research was performed evaluate months treatment outcome some direct acting 35 patients (26 3) below 30 years age using relevant biological parameters. Results: total yielded pooled SVR 85% after twelve weeks commonly used evaluation. Conclusion: Commonly Sialkot, Pakistan showed effectiveness pts having genotypes 1, 2, & 5. Keywords: virus, 3, drugs, function tests, renal tests